Global Coronary Artery Bypass Graft Procedures Market Report and Forecast 2024-2032

According to the report, the global coronary artery bypass graft procedures market grew significantly in 2022. Aided by the aging population, rising prevalence of coronary artery disease, and technological innovations in surgical techniques, the market is projected to further grow at a CAGR of 2.5% between 2024 and 2032 reaching a value of approximate USD 22.87 billion by 2032.

Coronary artery bypass grafting is a surgical procedure used to treat coronary artery disease, a condition characterised by the narrowing or blockage of the coronary arteries that supply blood to the heart muscle. During a CABG procedure, a surgeon creates bypasses or alternative pathways for blood flow around the blocked or narrowed arteries, thereby restoring blood supply to the heart muscle and alleviating symptoms.

As per the coronary artery bypass graft procedures market analysis, the mounting occurrence of cardiovascular diseases, particularly in urban settings, has intensified the global demand for CABG procedures. Sedentary lifestyles, rising obesity rates, heightened stress, and poor dietary choices are among the predominant factors contributing to this surge. Furthermore, an ageing global population, especially in developed nations, faces a higher risk of developing coronary complications, thus augmenting the need for CABG surgeries.

Technological advancements in the medical domain further propel the coronary artery bypass graft procedures market demand. The rise in minimally invasive surgical procedures, enhanced imaging techniques, and improved post-operative care tools have broadened the possibilities in CABG treatments. These innovations have not only optimised the success rates but have also reduced recovery times and potential complications.

Moreover, the healthcare industry's ongoing investments in research and development aim to make CABG procedures safer, more efficient, and more accessible to patients worldwide and further increases the coronary artery bypass graft procedures market size. This includes the exploration of alternative materials for grafts, the development of robotic-assisted CABG procedures, and techniques to minimise surgical trauma.

Another pivotal factor boosting the market is the expanding healthcare infrastructure in developing nations. Governments and private entities are increasingly recognising the significance of cardiac care, resulting in the establishment of specialised cardiac centres and the upskilling of medical professionals which contributes to the coronary artery bypass graft procedures market growth. Such initiatives are bridging the gap between demand and the availability of cardiac treatments, including CABG surgeries.

Market Segmentation

The market can be divided based on graft type, surgery type, and region.

Market Breakup by Graft Type

• Saphenous Vein Grafts
• Internal Thoracic Artery Grafts
• Others

Market Breakup by Surgery Type

• Single CABG Surgery
• Double CABG Surgery
• Triple CABG Surgery
• Quadruple CABG Surgery

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global coronary artery bypass graft procedures market. Some of the major players explored in the report are as follows:

• Boston Scientific Corporation (NYSE: BSX)
• KARL STORZ GmbH & Co. KG
• Ethicon US, LLC. (Johnson & Johnson)
• Genesee Biomedical, Inc.
• MAQUET Holding B.V. & Co.KG
• Others